Selected research
Industry Research
Custom Plasmid Production and Manufacturing Industry Research Report 2026
Market perspective
The global Custom Plasmid Production and Manufacturing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom Plasmid Production and Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Plasmid Production and Manufacturing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Plasmid Production and Manufacturing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Plasmid Production and Manufacturing include Aldevron, Catalent Biologics, Polyplus, Creative Biogene, PlasmidFactory GmbH, Bionexus, Wuxi Advanced Therapies, Charles River Laboratories and Plasmid Biosciences, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom Plasmid Production and Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Plasmid Production and Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom Plasmid Production and Manufacturing Market by Company
Aldevron
Catalent Biologics
Polyplus
Creative Biogene
PlasmidFactory GmbH
Bionexus
Wuxi Advanced Therapies
Charles River Laboratories
Plasmid Biosciences
Sartorius AG
Porton Advanced
Oxford Genetics LTD
uBriGene
TriLink BioTechnologies
Vectorbuilder
Custom Plasmid Production and Manufacturing Segment by Type
Research Grade
Industrial Grade
GMP Grade
Others
Custom Plasmid Production and Manufacturing Segment by Application
Gene Therapy
Basic Research
Drug Development
Others
Custom Plasmid Production and Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Plasmid Production and Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Plasmid Production and Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Plasmid Production and Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom Plasmid Production and Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Research Grade
- Industrial Grade
- GMP Grade
- Others
Applications
- Gene Therapy
- Basic Research
- Drug Development
- Others
Companies covered
- Aldevron
- Catalent Biologics
- Polyplus
- Creative Biogene
- PlasmidFactory GmbH
- Bionexus
- Wuxi Advanced Therapies
- Charles River Laboratories
- Plasmid Biosciences
- Sartorius AG
- Porton Advanced
- Oxford Genetics LTD
- uBriGene
- TriLink BioTechnologies
- Vectorbuilder
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom Plasmid Production and Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Research Grade
- 2.2.3 Industrial Grade
- 2.2.4 GMP Grade
- 2.2.5 Others
- 2.3 Custom Plasmid Production and Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Gene Therapy
- 2.3.3 Basic Research
- 2.3.4 Drug Development
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Custom Plasmid Production and Manufacturing Breakdown Data by Type
- 3.1 Global Custom Plasmid Production and Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global Custom Plasmid Production and Manufacturing Forecasted Market Size by Type (2027-2032)
4 Custom Plasmid Production and Manufacturing Breakdown Data by Application
- 4.1 Global Custom Plasmid Production and Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global Custom Plasmid Production and Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom Plasmid Production and Manufacturing Market Perspective (2021-2032)
- 5.2 Global Custom Plasmid Production and Manufacturing Growth Trends by Region
- 5.2.1 Global Custom Plasmid Production and Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom Plasmid Production and Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 Custom Plasmid Production and Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 Custom Plasmid Production and Manufacturing Market Dynamics
- 5.3.1 Custom Plasmid Production and Manufacturing Industry Trends
- 5.3.2 Custom Plasmid Production and Manufacturing Market Drivers
- 5.3.3 Custom Plasmid Production and Manufacturing Market Challenges
- 5.3.4 Custom Plasmid Production and Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom Plasmid Production and Manufacturing Players by Revenue
- 6.1.1 Global Top Custom Plasmid Production and Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global Custom Plasmid Production and Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom Plasmid Production and Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom Plasmid Production and Manufacturing Head Office and Area Served
- 6.4 Global Custom Plasmid Production and Manufacturing Players, Product Type & Application
- 6.5 Global Custom Plasmid Production and Manufacturing Manufacturers Established Date
- 6.6 Global Custom Plasmid Production and Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom Plasmid Production and Manufacturing Market Size (2021-2032)
- 7.2 North America Custom Plasmid Production and Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom Plasmid Production and Manufacturing Market Size by Country (2021-2026)
- 7.4 North America Custom Plasmid Production and Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom Plasmid Production and Manufacturing Market Size (2021-2032)
- 8.2 Europe Custom Plasmid Production and Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom Plasmid Production and Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe Custom Plasmid Production and Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Plasmid Production and Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific Custom Plasmid Production and Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom Plasmid Production and Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom Plasmid Production and Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom Plasmid Production and Manufacturing Market Size (2021-2032)
- 10.2 South America Custom Plasmid Production and Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom Plasmid Production and Manufacturing Market Size by Country (2021-2026)
- 10.4 South America Custom Plasmid Production and Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Plasmid Production and Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa Custom Plasmid Production and Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom Plasmid Production and Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom Plasmid Production and Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aldevron
- 12.1.1 Aldevron Company Information
- 12.1.2 Aldevron Business Overview
- 12.1.3 Aldevron Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.1.4 Aldevron Custom Plasmid Production and Manufacturing Product Portfolio
- 12.1.5 Aldevron Recent Developments
- 12.2 Catalent Biologics
- 12.2.1 Catalent Biologics Company Information
- 12.2.2 Catalent Biologics Business Overview
- 12.2.3 Catalent Biologics Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.2.4 Catalent Biologics Custom Plasmid Production and Manufacturing Product Portfolio
- 12.2.5 Catalent Biologics Recent Developments
- 12.3 Polyplus
- 12.3.1 Polyplus Company Information
- 12.3.2 Polyplus Business Overview
- 12.3.3 Polyplus Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.3.4 Polyplus Custom Plasmid Production and Manufacturing Product Portfolio
- 12.3.5 Polyplus Recent Developments
- 12.4 Creative Biogene
- 12.4.1 Creative Biogene Company Information
- 12.4.2 Creative Biogene Business Overview
- 12.4.3 Creative Biogene Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.4.4 Creative Biogene Custom Plasmid Production and Manufacturing Product Portfolio
- 12.4.5 Creative Biogene Recent Developments
- 12.5 PlasmidFactory GmbH
- 12.5.1 PlasmidFactory GmbH Company Information
- 12.5.2 PlasmidFactory GmbH Business Overview
- 12.5.3 PlasmidFactory GmbH Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.5.4 PlasmidFactory GmbH Custom Plasmid Production and Manufacturing Product Portfolio
- 12.5.5 PlasmidFactory GmbH Recent Developments
- 12.6 Bionexus
- 12.6.1 Bionexus Company Information
- 12.6.2 Bionexus Business Overview
- 12.6.3 Bionexus Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.6.4 Bionexus Custom Plasmid Production and Manufacturing Product Portfolio
- 12.6.5 Bionexus Recent Developments
- 12.7 Wuxi Advanced Therapies
- 12.7.1 Wuxi Advanced Therapies Company Information
- 12.7.2 Wuxi Advanced Therapies Business Overview
- 12.7.3 Wuxi Advanced Therapies Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.7.4 Wuxi Advanced Therapies Custom Plasmid Production and Manufacturing Product Portfolio
- 12.7.5 Wuxi Advanced Therapies Recent Developments
- 12.8 Charles River Laboratories
- 12.8.1 Charles River Laboratories Company Information
- 12.8.2 Charles River Laboratories Business Overview
- 12.8.3 Charles River Laboratories Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.8.4 Charles River Laboratories Custom Plasmid Production and Manufacturing Product Portfolio
- 12.8.5 Charles River Laboratories Recent Developments
- 12.9 Plasmid Biosciences
- 12.9.1 Plasmid Biosciences Company Information
- 12.9.2 Plasmid Biosciences Business Overview
- 12.9.3 Plasmid Biosciences Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.9.4 Plasmid Biosciences Custom Plasmid Production and Manufacturing Product Portfolio
- 12.9.5 Plasmid Biosciences Recent Developments
- 12.10 Sartorius AG
- 12.10.1 Sartorius AG Company Information
- 12.10.2 Sartorius AG Business Overview
- 12.10.3 Sartorius AG Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.10.4 Sartorius AG Custom Plasmid Production and Manufacturing Product Portfolio
- 12.10.5 Sartorius AG Recent Developments
- 12.11 Porton Advanced
- 12.11.1 Porton Advanced Company Information
- 12.11.2 Porton Advanced Business Overview
- 12.11.3 Porton Advanced Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.11.4 Porton Advanced Custom Plasmid Production and Manufacturing Product Portfolio
- 12.11.5 Porton Advanced Recent Developments
- 12.12 Oxford Genetics LTD
- 12.12.1 Oxford Genetics LTD Company Information
- 12.12.2 Oxford Genetics LTD Business Overview
- 12.12.3 Oxford Genetics LTD Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.12.4 Oxford Genetics LTD Custom Plasmid Production and Manufacturing Product Portfolio
- 12.12.5 Oxford Genetics LTD Recent Developments
- 12.13 uBriGene
- 12.13.1 uBriGene Company Information
- 12.13.2 uBriGene Business Overview
- 12.13.3 uBriGene Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.13.4 uBriGene Custom Plasmid Production and Manufacturing Product Portfolio
- 12.13.5 uBriGene Recent Developments
- 12.14 TriLink BioTechnologies
- 12.14.1 TriLink BioTechnologies Company Information
- 12.14.2 TriLink BioTechnologies Business Overview
- 12.14.3 TriLink BioTechnologies Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.14.4 TriLink BioTechnologies Custom Plasmid Production and Manufacturing Product Portfolio
- 12.14.5 TriLink BioTechnologies Recent Developments
- 12.15 Vectorbuilder
- 12.15.1 Vectorbuilder Company Information
- 12.15.2 Vectorbuilder Business Overview
- 12.15.3 Vectorbuilder Revenue in Custom Plasmid Production and Manufacturing Business (2021-2026)
- 12.15.4 Vectorbuilder Custom Plasmid Production and Manufacturing Product Portfolio
- 12.15.5 Vectorbuilder Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst